Short Wave Yep. They Injected CRISPR Into An Eyeball
Mar 19, 2020
The revolutionary gene-editing tool CRISPR is making waves in medicine. A groundbreaking treatment directly edits DNA inside the body for patients with genetic vision loss. Experts discuss the potential of restoring sight for those with Leber congenital amaurosis. The innovative approach involves injecting modified viruses into the retina, opening doors to new treatments for various genetic disorders. Safety and broader implications for genetic medicine are also key topics of conversation.
AI Snips
Chapters
Transcript
Episode notes
First In-Body CRISPR Treatment
- Doctors attempted CRISPR gene editing inside a patient's body for the first time.
- The procedure treated a genetic form of blindness called Leber congenital amaurosis.
Leber Congenital Amaurosis
- Leber congenital amaurosis affects the retina, impacting light and color detection.
- It's a leading cause of blindness in children, often starting at birth.
Expanding CRISPR's Reach
- In-body CRISPR opens possibilities for treating conditions previously inaccessible.
- This includes brain diseases and muscle diseases like muscular dystrophy.